On 3 February, Gilead Sciences, Inc. (NASDAQ:GILD) announced its results of operations for the fourth quarter and full year 2014. Total revenues for the fourth quarter of 2014 were $7.3 billion compared to $3.1 billion for the fourth quarter ofRead More

Regions Financial Corporation (NYSE:RF) is scheduled to present at the upcoming 2015 Credit Suisse Financial Services Forum. Regions executives will make a presentation beginning at 8:45 a.m. ET on Tuesday, February 10, 2015. On Friday shares of Regions Financial CorporationRead More

On 3 February, Actions Semiconductor Co., Ltd. (NASDAQ:ACTS) reported Revenue for the fourth quarter of 2014 was $13.9 million, as compared to revenue of $13.1 million for the third quarter of 2014, and $17.6 million for the fourth quarter ofRead More

Achillion Pharmaceuticals (NASDAQ:ACHN) CFO Mary Kay Fenton sold 13,125 shares of the stock on the open market in a transaction dated Friday, January 23rd. The shares were sold at an average price of $16.00, for a total value of $210,000.00.Read More

Yahoo! Inc. (NASDAQ:YHOO) CEO Marissa Mayer will participate in a question-and-answer session at the Goldman Sachs Technology and Internet Conference in San Francisco. The session is scheduled to begin on Wednesday, February 11, 2015, at 12:30 p.m. PT / 3:30Read More

Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), CFO Mary Kay Fenton sold 13,125 shares of the company’s stock in a transaction dated Friday, January 23rd. The stock was sold at an average price of $16.00, for a total value of $210,000.00. On WednesdayRead More

Sirius XM Holdings Inc. (NASDAQ:SIRI) and the PGA have announced an extension to their contract which will give golf fans nationwide coverage through 2017. The PGA has been a satellite radio staple for years, and though Tiger Woods is notRead More

Achillion Pharmaceuticals (NASDAQ:ACHN) CFO Mary Kay Fenton sold 13,125 shares of the stock on the open market in a transaction dated Friday, January 23rd. The shares were sold at an average price of $16.00, for a total transaction of $210,000.00.Read More

Gilead Sciences Inc. (NASDAQ:GILD) reported Total revenues of $7.3 billion were no comparison to the year-ago figure of $3.1 billion. Quarterly revenues were above the Zacks Consensus Estimate of $6.7 billion. Full-year 2014 revenues increased 122.2% to $24.9 billion, toppingRead More

Equities research analysts at Jefferies Group cut their target price on shares of Transocean Ltd. (NYSE:RIG) from $20.00 to $17.00 in a research note issued to investors on Thursday. The firm currently has a “hold” rating on the stock. JefferiesRead More